RADNOR, Pa. , May 12, 2022 /PRNewswire/ — The board of directors of Avantor, Inc. (NYSE: AVTR) a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries announced the election of Jonathan Peacock, 64, as chairman effective at the end of today’s annual meeting of stockholders. Peacock, a... Read more
BOSTON – May 12, 2022 – GE Healthcare has entered into an agreement to invest up to $50 million in Israeli start-up Pulsenmore, marking another strategic step forward in enabling precision health. This investment is aimed at accelerating global adoption of Pulsenmore’s homecare ultrasound solutions and will also support their goal to pursue U.S. FDA... Read more
Notice of Dividends of Surplus | IR News | News Release ＆ IR News | Investor Relations Read more
Notice Regarding Dividends of surplus Read more
ANDOVER, Mass., May 05, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of technologies that enable advanced processes and improve productivity, today announced it has been recognized as a “3+” company for having three or more female board members by 50/50 Read more
Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis Revenue driven by base revenue growth of 8.2% as reported, 10.2% currency-neutral, partially offset by decline in worldwide COVID-only testing revenues to $214 million from $474 million in the prior year GAAP diluted EPS of $1.50; adjusted diluted EPS of $3.18 Company... Read more
MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million, a 14% increase compared with $29.0 million in the prior year period. Delivered a record 50 Sequel II/IIe systems during the quarter compared to 41... Read more
Q1 2022 revenue growth of 7.3% year-over-year (yoy); organic revenue growth of 10.5% Q1 2022 GAAP EPS $0.41; non-GAAP EPS $0.49, up 11.4% yoy Raising fiscal year 2022 organic revenue outlook on strong demand for the Company’s high-performance life science tools, scientific instruments and diagnostic solutions BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced... Read more
Continuing strong underlying demand: Organic orders growth of 14%, up 12% on a reported basis Revenue of $1.3 billion, up 1% on a reported basis, up 4% organically Earnings per share $0.45; adjusted earnings per share $0.47 Raising full-year organic revenue guidance to a range of 4% to 6%, and adjusted earnings per share to... Read more